13 May 2022 - Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out
New data by PwC for the Association of the British Pharmaceutical Industry highlights the potential benefits of increased investment in clinically and cost-effective new medicines to patients, society and the economy.